Study of Invasive Pneumococcal Infection in Adults with Reference to Penicillin Resistance

ABSTRACT

Background: Invasive pneumococcal infections often prove rapidly fatal, even where good medical treatment is readily available. In developed countries, up to 20% of people who contract pneumococcal meningitis die; however, in developing world, mortality is closer to 50%, even among hospitalized patients. The World Health Organization estimated 600,000–800,000 adult deaths each year from pneumococcal pneumonia, meningitis, and sepsis.

Aims: This study aims to estimate isolation rate of invasive pneumococcal infection in adults, to determine the antimicrobial susceptibility profile of Streptococcus pneumoniae. isolates and to study the associated risk factors.

Materials and Methods: A total of 120 patients with suspected invasive infection such as meningitis, septicemia, and pleural effusion, were included in the study. Various clinical specimens such as pus, cerebrospinal fluid, and other sterile body fluids were processed for isolation and identification of S. pneumoniae. Kirby–Bauer disc diffusion method was performed to determine the antimicrobial susceptibility profile. Minimum inhibitory concentration test was performed to determine the penicillin resistance.

Results: Of 120 patients, 40 (33.33%) cases were proven by culture to have an invasive pneumococcal infection. The most common clinical condition observed was meningitis followed by pneumonia with pleural effusion and sepsis. Pneumococcal isolates exhibited 40% resistance to cotrimoxazole and 12.73% to chloramphenicol. Two meningeal isolates exhibited penicillin resistance. Comorbidities observed in 21 (52.5%) cases were mainly Diabetes mellitus, smoking, and alcoholism.

Conclusions: Invasive pneumococcal infection has poor prognosis and penicillin‑resistant strains have become increasingly common. This study emphasizes the importance of judicious use of antibiotics, especially to refrain their use in mild self-limiting upper respiratory infections.

Key words

Adults - invasive pneumococcal infection - penicillin resistance

Publication History

Article published online:
19 February 2020

• REFERENCES

• 1 Janoff EN, Musher DM. Streptococcus pneumoniae. In: Bennett JE, editor. Mandell, Douglas and Bennett's Principle and Practice of Infectious Diseases. 8^th ed., Vol. 1. Canada: Elsevier Saunders Publication; 2015. p. 2310-25.
• 2 Schrag SJ, Beall B, Dowell S. Resistant Pneumococcal Infections: The Burden of Disease and Challenges in Monitoring and Controlling Antimicrobial Resistance. Available from: http://www.who.int/csr/resources/publications/drugresist/Pneumonoccal_infections.pdf. [Last accessed on 2015 Aug 12].
• 3 Hung IF, Tantawichien T, Tsai YH, Patil S, Zotomayor R. Regional epidemiology of invasive pneumococcal disease in Asian adults: Epidemiology, disease burden, serotype distribution, and antimicrobial resistance patterns and prevention. Int J Infect Dis 2013;17:e364-73.
• 4 Thomas K. Epidemiology of Invasive Pneumococcal Disease in Adults in India. Association of Physicians; 2007. Available from: http://www.apiindia.org/pdf/medicine_update_2007/101.pdf. [Last accessed on 2015 Aug 12].
• 5 Drijkoningen JJ, Rohde GG. Pneumococcal infection in adults: Burden of disease. Clin Microbiol Infect 2014;20 Suppl 5:45-51.
• 6 Thomas K, Mukkai Kesavan L, Veeraraghavan B, Jasmine S, Jude J, Shubankar M, et al. Invasive pneumococcal disease associated with high case fatality in India. J Clin Epidemiol 2013;66:36-43.
• 7 Lynch JP 3^rd, Zhanel GG. Streptococcus pneumoniae. Epidemiology, risk factors, and strategies for prevention. Semin Respir Crit Care Med 2009;30:189-209.
• 8 Kim SH, Song JH, Chung DR, Thamlikitkul V, Yang Y, Wang H,et al. Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae.isolates in Asian countries: An Asian Network for Surveillance of Resistant Pathogens (ANSORP) study. Antimicrob Agents Chemother 2012;56:1418-26.
• 9 Song JH, Jung SI, Ko KS, Kim NY, Son JS, Chang HH, et al. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae.isolates in Asia (an ANSORP study). Antimicrob Agents Chemother 2004;48:2101-7.
• 10 Shin J, Baek JY, Kim SH, Song JH, Ko KS. Predominance of ST320 among Streptococcus pneumoniae.serotype 19A isolates from 10 Asian countries. J Antimicrob Chemother 2011;66:1001-4.
• 11 Konemann EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC Jr. Gram positive cocci part II: Streptococci, enterococci and the "Streptococcus-like" bacteria. In: Koneman's Color Atlas and Textbook of Diagnostic Microbiology. 6^th ed. Baltimore: Lippincott Williams and Wilkins; 2006. p. 689-93.
• 12 Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-fourth Informational Supplement M100-S24. Wayne, PA, USA: CLSI; 2014.
• 13 Thomas K, Lalitha MK, Arora NK, Das B, Awashti S, Amita J, et al. The IndiaCLEN Invasive Bacterial Infection Surveillance (IBIS) Study: The Burden of Vaccine Preventable Illness. Monograph No. 6, December, 1996. Available from: http://www.inclentrust.org/inclen/uploadedbyfck/file/publication/the%20inclen/Annex%201-IBISI%202final.pdf. [Last accessed on 2015 Aug 12].
• 14 Mani R, Pradhan S, Nagarathna S, Wasiulla R, Chandramuki A. Bacteriological profile of community acquired acute bacterial meningitis: A ten-year retrospective study in a tertiary neurocare centre in South India. Indian J Med Microbiol 2007;25:108-14.
• 15 Ananthanarayanan R, Paniker CK. Pneumococcus. In: Paniker CK, editor. Textbook of Microbiology. 5^th ed. Chennai: Orient Longman Ltd.; 1997. p. 198-203.
• 16 Molander V, Elisson C, Balaji V, Backhaus E, John J, Vargheese R, et al. Invasive pneumococcal infections in Vellore, India: Clinical characteristics and distribution of serotypes. BMC Infect Dis 2013;13:532.
• 17 Verhaegen J, Flamaing J, De Backer W, Delaere B, Van Herck K, Surmont F, et al. Epidemiology and outcome of invasive pneumococcal disease among adults in Belgium, 2009-2011. Euro Surveill 2014;19:14-22.